Differential effects of leptin and adiponectin in endothelial angiogenesis

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Adya, Raghu ^a   Tan, Bee K ^a,b   Randeva, Harpal S ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ENDOTHELIAL ADHESION MOLECULE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTIN; NITRIC OXIDE; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG; ADIPOCYTOKINE;

ANGIOGENESIS; ARTICLE; CARDIOVASCULAR DISEASE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN INTERACTION; VASCULITIS; VASODILATATION; ANIMAL; ATHEROSCLEROSIS; BLOOD; CHEMISTRY; ISCHEMIA; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADIPOKINES; ADIPONECTIN; ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; ISCHEMIA; LEPTIN; MICE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; NITRIC OXIDE; OBESITY;

EID: 84947648682     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/648239     Document Type: Article

References (126)

1. E. S. Gordon, "Non-esterified fatty acids in blood of obese and lean subjects, "The American Journal of Clinical Nutrition, vol. 8, pp. 740-747, 1960.
2. G. Boden and G. I. Shulman, "Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and-cell dysfunction, " European Journal of Clinical Investigation, vol. 32, no. 3, pp. 14-23, 2002.
3. A. H. Lichtenstein, "Trans fatty acids, plasma lipid levels, and risk of developing cardiovascular disease: a statement for healthcare professionals from the AmericanHeart Association, " Circulation, vol. 95, no. 11, pp. 2588-2590, 1997.
4. J. A. Kim, M. Montagnani, K. K. Kwang, and M. J. Quon, "Reciprocal relationships between insulin resistance and endothelial dysfunction-molecular and pathophysiological mechanisms, " Circulation, vol. 113, no. 15, pp. 1888-1904, 2006.
5. W. Aldhahi and O. Hamdy, "Adipokines, inflammation, and the endothelium in diabetes, " Current Diabetes Reports, vol. 3, no. 4, pp. 293-298, 2003.
6. D. C. W. Lau, B. Dhillon, H. Yan, P. E. Szmitko, and S. Verma, "Adipokines: molecular links between obesity and atheroslcerosis, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 288, no. 5, pp. H2031-H2041, 2005.
7. A. Avogaro and S. V. de Kreutzenberg, "Mechanisms of endothelial dysfunction in obesity, " Clinica Chimica Acta, vol. 360, no. 1-2, pp. 9-26, 2005.
8. Y. B. Tripathi and V. Pandey, "Obesity and endoplasmic reticulum (ER) stresses, " Frontiers in Immunology, vol. 3, article 240, 2012.
9. A. Bouloumi, J. Bauersachs, W. Linz et al., "Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production, " Hypertension, vol. 30, no. 4, pp. 934-941, 1997.
10. R. Stocker and J. F. Keaney Jr., "Role of oxidative modifications in atherosclerosis, " Physiological Reviews, vol. 84, no. 4, pp. 1381-1478, 2004.
11. D. Cooper, K. Y. Stokes, A. Tailor, and D. N. Granger, "Oxidative stress promotes blood cell-endothelial cell interactions in the microcirculation, " Cardiovascular Toxicology, vol. 2, no. 3, pp. 165-180, 2002.
12. A. R. Subauste and C. F. Burant, "Role of FoxO1 in FFA-induced oxidative stress in adipocytes, " The American Journal of Physiology-Endocrinology andMetabolism, vol. 293, no. 1, pp. E159-E164, 2007.
13. P. E. Scherer, S. Williams, M. Fogliano, G. Baldini, and H. F. Lodish, "A novel serum protein similar to C1q, produced exclusively in adipocytes, " The Journal of Biological Chemistry, vol. 270, no. 45, pp. 26746-26749, 1995.
14. T. Yamauchi, J. Kamon, H. Waki et al., "The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity, " Nature Medicine, vol. 7, no. 8, pp. 941-946, 2001.
15. M. E. Trujillo and P. E. Scherer, "Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome, " Journal of InternalMedicine, vol. 257, no. 2, pp. 167-175, 2005.
16. H. Okui, S. Hamasaki, S. Ishida et al., "Adiponectin is a better predictor of endothelial function of the coronary artery than HOMA-R, body mass index, immunoreactive insulin, or triglycerides, " International Journal of Cardiology, vol. 126, no. 1, pp. 53-61, 2008.
17. E. Hu, P. Liang, and B. M. Spiegelman, "AdipoQ is a novel adipose-specific gene dysregulated in obesity, " Journal of Biological Chemistry, vol. 271, no. 18, pp. 10697-10703, 1996.
18. K. Maeda, K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, and K. Matsubara, "cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1), " Biochemical and Biophysical Research Communications, vol. 221, no. 2, pp. 286-289, 1996.
19. Y. Nakano, T. Tobe, N. H. Choi-Miura, T. Mazda, and M. Tomita, "Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma, " Journal of Biochemistry, vol. 120, no. 4, pp. 803-812, 1996.
20. Y. Wang, K. S. L. Lam, M.-H. Yau, and A. Xu, "Post-translational modifications of adiponectin: mechanisms and functional implications, " Biochemical Journal, vol. 409, no. 3, pp. 623-633, 2008.
21. H. Waki, T. Yamauchi, J. Kamon et al., "Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1, " Endocrinology, vol. 146, no. 2, pp. 790-796, 2005.
22. T. Yamauchi, J. Kamon, Y. Ito et al., "Cloning of adiponectin receptors that mediate antidiabetic metabolic effects, " Nature, vol. 423, no. 6941, pp. 762-769, 2003.
23. I. Kharroubi, J. Rasschaert, D. L. Eizirik, and M. Cnop, "Expression of adiponectin receptors in pancreatic beta cells, " Biochemical and Biophysical Research Communications, vol. 312, no. 4, pp. 1118-1122, 2003.
24. G. Chinetti, C. Zawadski, J. C. Fruchart, and B. Staels, "Expression of adiponectin receptors in humanmacrophages and regulation by agonists of the nuclear receptors PPAR, PPAR, and LXR, " Biochemical and Biophysical Research Communications, vol. 314, no. 1, pp. 151-158, 2004.
25. T.-S. Tsao, E. Tomas, H. E. Murrey et al., "Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity: different oligomers activate different signal transduction pathways, " The Journal of Biological Chemistry, vol. 278, no. 50, pp. 50810-50817, 2003.
26. M. L. Narasimhan, M. A. Coca, J. B. Jin et al., "Osmotin is a homolog of mammalian adiponectin and controls apoptosis in yeast through a homolog of mammalian adiponectin receptor, " Molecular Cell, vol. 17, no. 2, pp. 171-180, 2005.
27. M. Blüher, J. W. Bullen Jr., J. H. Lee et al., "Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training, " Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 6, pp. 2310-2316, 2006.
28. N. Viguerie, H. Vidal, P. Arner et al., "Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets, " Diabetologia, vol. 48, no. 1, pp. 123-131, 2005.
29. A. E. Civitarese, C. P. Jenkinson, D. Richardson et al., "Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes, " Diabetologia, vol. 47, no. 5, pp. 816-820, 2004.
30. H. Zhang, Y. Park, and C. Zhang, "Coronary and aortic endothelial function affected by feedback between adiponectin and tumor necrosis factor in type 2 diabetic mice, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 11, pp. 2156-2163, 2010.
31. N. Ouchi, H. Kobayashi, S. Kihara et al., "Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells, " The Journal of Biological Chemistry, vol. 279, no. 2, pp. 1304-1309, 2004.
32. N. Ouchi, S. Kihara, Y. Arita et al., "Adiponectin, an adipocytederived plasma protein, inhibits endothelial NF-B signaling through a cAMP-dependent pathway, " Circulation, vol. 102, no. 11, pp. 1296-1301, 2000.
33. E. Bråkenhielm, N. Veitonmäki, R. Cao et al., "Adiponectininduced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 8, pp. 2476-2481, 2004.
34. K. Mahadev, X. Wu, S. Donnelly, R. Ouedraogo, A. D. Eckhart, and B. J. Goldstein, "Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells, " Cardiovascular Research, vol. 78, no. 2, pp. 376-384, 2008.
35. R. Adya, B. K. Tan, J. Chen, and H. S. Randeva, "Protective actions of globular and full-length adiponectin on human endothelial cells: novel insights into adiponectin-induced angiogenesis, " Journal of Vascular Research, vol. 49, no. 6, pp. 534-543, 2012.
36. H. Motoshima, X. Wu, K. Mahadev, and B. J. Goldstein, "Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL, " Biochemical and Biophysical Research Communications, vol. 315, no. 2, pp. 264-271, 2004.
37. P.-H. Huang, J.-S. Chen, H.-Y. Tsai et al., "Globular adiponectin improves high glucose-suppressed endothelial progenitor cell function through endothelial nitric oxide synthase dependent mechanisms, " Journal ofMolecular and Cellular Cardiology, vol. 51, no. 1, pp. 109-119, 2011.
38. A. Bouloumié, H. C. A. Drexler, M. Lafontan, and R. Busse, "Leptin, the product of Ob gene, promotes angiogenesis, " Circulation Research, vol. 83, no. 10, pp. 1059-1066, 1998.
39. Y. Hattori, S. Hattori, K. Akimoto et al., "Globular adiponectin activates nuclear factor-kappaB and activating protein-1 and enhances angiotensin II-induced proliferation in cardiac fibroblasts, " Diabetes, vol. 56, no. 3, pp. 804-808, 2007.
40. P. Bobbert, S. Antoniak, H. P. Schultheiss, and U. Rauch, "Globular adiponectin but not full-length adiponectin induces increased procoagulability in human endothelial cells, " Journal of Molecular and Cellular Cardiology, vol. 44, no. 2, pp. 388-394, 2008.
41. F. Addabbo, C. Nacci, L. de Benedictis et al., "Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via adipoR1/NF-B/COX-2 signaling in human aortic endothelial cells, " American Journal of Physiology-Endocrinology and Metabolism, vol. 301, no. 6, pp. E1143-E1154, 2011.
42. A. Bouloumié, T. Marumo, M. Lafontan, and R. Busse, "Leptin induces oxidative stress in human endothelial cells, " The FASEB Journal, vol. 13, no. 10, pp. 1231-1238, 1999.
43. P. Cirillo, V. Angri, S. de Rosa et al., "Pro-atherothrombotic effects of leptin in human coronary endothelial cells, " Thrombosis and Haemostasis, vol. 103, no. 5, pp. 1065-1075, 2010.
44. C. Vecchione, A. Maffei, S. Colella et al., "Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway, " Diabetes, vol. 51, no. 1, pp. 168-173, 2002.
45. C. Hug, J. Wang, N. S. Ahmad, J. S. Bogan, T.-S. Tsao, and H. F. Lodish, "T-cadherin is a receptor for hexameric and highmolecular-weight forms of Acrp30/adiponectin, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 28, pp. 10308-10313, 2004.
46. Y. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman, "Positional cloning of the mouse obese gene and its human homolog, " Nature, vol. 372, pp. 425-432, 1994.
47. S. Margetic, C. Gazzola, G. G. Pegg, and R. A. Hill, "Leptin: a review of its peripheral actions and interactions, " International Journal of Obesity, vol. 26, no. 11, pp. 1407-1433, 2002.
48. J. Betowski, G. Wojcicka, and A. Jamroz, "Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia, " Atherosclerosis, vol. 170, no. 1, pp. 21-29, 2003.
49. M. L. G. Correia and K. Rahmouni, "Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome, " Diabetes, Obesity and Metabolism, vol. 8, no. 6, pp. 603-610, 2006.
50. N. Werner and G. Nickenig, "From fat fighter to risk factor: the zigzag trek of leptin, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 1, pp. 7-9, 2004.
51. A. M. Wallace, A. D. McMahon, C. J. Packard et al., "Plasma leptin andthe risk of cardiovasculardisease in theWestof Scotland Coronary Prevention Study (WOSCOPS), " Circulation, vol. 104, no. 25, pp. 3052-3056, 2001.
52. R. Wolk, P. Berger, R. J. Lennon, E. S. Brilakis, B. D. Johnson, and V. K. Somers, "Plasma leptin and prognosis in patients with established coronary atherosclerosis, " Journal of the American College of Cardiology, vol. 44, no. 9, pp. 1819-1824, 2004.
53. G. Frühbeck, "Intracellular signalling pathways activated by leptin, " The Biochemical Journal, vol. 393, no. 1, pp. 7-20, 2006.
54. M. R. Sierra-Honigmann, A. K. Nath, C. Murakami et al., "Biological action of leptin as an angiogenic factor, " Science, vol. 281, no. 5383, pp. 1683-1686, 1998.
55. K. Rahmouni and W. G. Haynes, "Leptin and the cardiovascular system, " Recent Progress in Hormone Research, vol. 59, pp. 225-244, 2004.
56. A. Avogaro and S. V. de Kreutzenberg, "Mechanisms of endothelial dysfunction in obesity, " Clinica Chimica Acta, vol. 360, no. 1-2, pp. 9-26, 2005.
57. J. M. Friedman and J. L. Halaas, "Leptin and the regulation of body weight in mammals, " Nature, vol. 395, no. 6704, pp. 763-770, 1998.
58. J. M. Friedman, "Modern science versus the stigma of obesity, " Nature Medicine, vol. 10, no. 6, pp. 563-569, 2004.
59. J. Ren, "Leptin and hyperleptinemia-from friend to foe for cardiovascular function, " The Journal of Endocrinology, vol. 181, no. 1, pp. 1-10, 2004.
60. H. Hsuchou, A. J. Kastin, H. Tu, N. Joan Abbott, P.-O. Couraud, and W. Pan, "Role of astrocytic leptin receptor subtypes on leptin permeation across hCMEC/D3 human brain endothelial cells, " Journal of Neurochemistry, vol. 115, no. 5, pp. 1288-1298, 2010.
61. H. Chen, M. Montagnani, T. Funahashi, I. Shimomura, and M. J. Quon, "Adiponectin stimulates production of nitric oxide in vascular endothelial cells, "The Journal of Biological Chemistry, vol. 278, no. 45, pp. 45021-45026, 2003.
62. R. Ouedraogo, X. D. Wu, S. Q. Xu et al., "Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway, " Diabetes, vol. 55, no. 6, pp. 1840-1846, 2006.
63. B. J. Goldstein and R. Scalia, "Adiponectin: a novel adipokine linking adipocytes and vascular function, "The Journal of Clinical Endocrinology andMetabolism, vol. 89, no. 6, pp. 2563-2568, 2004.
64. Y. Hattori, Y. Nakano, S. Hattori, A. Tomizawa, K. Inukai, and K. Kasai, "High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-B activation in vascular endothelial cells, " FEBS Letters, vol. 582, no. 12, pp. 1719-1724, 2008.
65. S.-Q. Xu, K. Mahadev, X. Wu et al., "Adiponectin protects against angiotensin II or tumor necrosis factor-induced endothelial cell monolayer hyperpermeability: role of cAMP/PKA signaling, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 5, pp. 899-905, 2008.
66. N. Ouchi, M. Ohishi, S. Kihara et al., "Association of hypoadiponectinemia with impaired vasoreactivity, " Hypertension, vol. 42, no. 3, pp. 231-234, 2003.
67. X. P. Chen, H. R. Zhang, S. McAfee, and C. H. Zhang, "The reciprocal relationship between adiponectin and LOX-1 in the regulation of endothelial dysfunction in ApoE knockout mice, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 299, no. 3, pp. H605-H612, 2010.
68. H. R. Zhang, Y. Park, and C. H. Zhang, "Coronary and aortic endothelial function affected by feedback between adiponectin and tumor necrosis factor alpha in type 2 diabetic mice, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 11, pp. 2156-2163, 2010.
69. V. Vachharajani, C. Cunningham, B. Yoza, J. Carson Jr., T. J. Vachharajani, and C. McCall, "Adiponectin-deficiency exaggerates sepsis-induced microvascular dysfunction in the mouse brain, " Obesity, vol. 20, no. 3, pp. 498-504, 2012.
70. K. C. B. Tan, A. Xu, W. S. Chow et al., "Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation, " Journal of Clinical Endocrinology andMetabolism, vol. 89, no. 2, pp. 765-769, 2004.
71. X. Xiao, Y. Dong, J. Zhong et al., "Adiponectin protects endothelial cells from the damages induced by the intermittent high level of glucose, " Endocrine, vol. 40, no. 3, pp. 386-393, 2011.
72. R. Ouedraogo, Y. Gong, B. Berzins et al., "Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo, " The Journal of Clinical Investigation, vol. 117, no. 6, pp. 1718-1726, 2007.
73. E. S. Biegelsen and J. Loscalzo, "Endothelial function and atherosclerosis, " Coronary Artery Disease, vol. 10, no. 4, pp. 241-256, 1999.
74. C. Weyer, T. Funahashi, S. Tanaka et al., "Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia, " Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 5, pp. 1930-1935, 2001.
75. R. Shibata, N. Ouchi, S. Kihara, K. Sato, T. Funahashi, and K. Walsh, "Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of AMP-activated protein kinase signaling, " Journal of Biological Chemistry, vol. 279, no. 27, pp. 28670-28674, 2004.
76. L. Shen, J. Miao, F. Yuan et al., "Overexpression of adiponectin promotes focal angiogenesis in the mouse brain following middle cerebral artery occlusion, " Gene Therapy, vol. 20, no. 1, pp. 93-101, 2013.
77. K. Man, K. T. P. Ng, A. Xu et al., "Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling, " Clinical Cancer Research, vol. 16, no. 3, pp. 967-977, 2010.
78. N. Ouchi, S. Kihara, Y. Arita et al., "Novel modulator for endothelial adhesionmolecules: adipocyte-derived plasma protein adiponectin, " Circulation, vol. 100, no. 25, pp. 2473-2476, 1999.
79. N. Ouchi, S. Kihara, Y. Arita et al., "Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages, " Circulation, vol. 103, no. 8, pp. 1057-1063, 2001.
80. M. Cheng, S. Hashmi, X. Mao, and Q. T. Zeng, "Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome, " The Canadian Journal of Cardiology, vol. 24, no. 5, pp. 385-390, 2008.
81. A. Tomizawa, Y. Hattori, K. Kasai, and Y. Nakano, "Adiponectin induces NF-B activation that leads to suppression of cytokineinducedNF-B activation in vascular endothelial cells: globular adiponectin vs. high molecular weight adiponectin, " Diabetes and Vascular Disease Research, vol. 5, no. 2, pp. 123-127, 2008.
82. Y. Xu, C. Zhang, N. Wang et al., "Adiponectin inhibits lymphotoxin-receptor-mediated NF-B signaling in human umbilical vein endothelial cells, " Biochemical and Biophysical Research Communications, vol. 404, no. 4, pp. 1060-1064, 2011.
83. R. Natarajan, F. N. Salloum, B. J. Fisher, R. C. Kukreja, and A. A. Fowler III, "Hypoxia inducible factor-1 upregulates adiponectin in diabetic mouse hearts and attenuates post-ischemic injury, " Journal of Cardiovascular Pharmacology, vol. 51, no. 2, pp. 178-187, 2008.
84. L. Li, J.-C. Mamputu, N. Wiernsperger, and G. Renier, "Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect ofmetformin, " Diabetes, vol. 54, no. 7, pp. 2227-2234, 2005.
85. E. Porreca, C. Di Febbo, L. Fusco, V. Moretta, M. Di Nisio, and F. Cuccurullo, "Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese women, " Atherosclerosis, vol. 172, no. 1, pp. 175-180, 2004.
86. G. Lembo, C. Vecchione, L. Fratta et al., "Leptin induces direct vasodilation through distinct endothelial mechanisms, " Diabetes, vol. 49, no. 2, pp. 293-297, 2000.
87. K. Matsuda, H. Teragawa, Y. Fukuda, K. Nakagawa, Y. Higashi, and K. Chayama, "Leptin causes nitric-oxide independent coronary artery vasolidation in humans, " Hypertension Research, vol. 26, no. 2, pp. 147-152, 2003.
88. A. Fortuo, A. Rodriuez, J. Gmez-Ambrosi et al., "Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta, " Endocrinology, vol. 143, no. 9, pp. 3555-3560, 2002.
89. A. U. Momin, N. Melikian, A. M. Shah et al., "Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: evidence for tissue specificity of leptin resistance, " European Heart Journal, vol. 27, no. 19, pp. 2294-2299, 2006.
90. S. Benkhoff, A. E. Loot, I. Pierson et al., "Leptin potentiates endothelium-dependent relaxation by inducing endothelial expression of neuronal no synthase, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, pp. 1605-1612, 2012.
91. K. M. Naseem, "The role of nitric oxide in cardiovascular diseases, "Molecular Aspects ofMedicine, vol. 26, no. 1-2, pp. 33-65, 2005.
92. J. D. Knudson, U. D. Dincer, C. Zhang et al., "Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction, "American Journal of Physiology-Heart and Circulatory Physiology, vol. 289, no. 1, pp. H48-H56, 2005.
93. S. I. Yamagishi, D. Edelstein, X. L. Du, Y. Kaneda, M. Guzmn, and M. Brownlee, " Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A, " The Journal of Biological Chemistry, vol. 276, pp. 25096-25100, 2001.
94. F. Maingrette and G. Renier, "Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C, " Diabetes, vol. 52, no. 8, pp. 2121-2128, 2003.
95. D. Cooper, K. Y. Stokes, A. Tailor, and D. N. Granger, "Oxidative stress promotes blood cell-endothelial cell interactions in the microcirculation, " Cardiovascular Toxicology, vol. 2, no. 3, pp. 165-180, 2002.
96. Y.-M. Leung and C.-Y. Kwan, "Dual vascular effects of leptin via endothelium: hypothesis and perspective, " The Chinese Journal of Physiology, vol. 51, no. 1, pp. 1-6, 2008.
97. Y. Park, F. W. Booth, S. Lee, M. J. Laye, and C. H. Zhang, "Physical activity opposes coronary vascular dysfunction induced during high fat feeding in mice, " The Journal of Physiology, vol. 590, no. 17, pp. 4255-4268, 2012.
98. H.-Y. Park, H. M. Kwon, H. J. Lim et al., "Potential role of leptin in angiogenesis: Leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro, " Experimental and Molecular Medicine, vol. 33, no. 2, pp. 95-102, 2001.
99. R. Cao, E. Brakenhielm, C. Wahlestedt, J. Thyberg, and Y. Cao, "Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF, " Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 11, pp. 6390-6395, 2001.
100. B. Stallmeyer, J. Pfeilschifter, and S. Frank, "Systemically and topically supplemented leptin fails to reconstitute a normal angiogenic response during skin repair in diabetic ob/ob mice, " Diabetologia, vol. 44, no. 4, pp. 471-479, 2001.
101. L. Wator, U. Razny, A. Balwierz et al., "Impaired leptin activity in New Zealand Obese mice: model of angiogenesis, " Genes and Nutrition, vol. 3, no. 3-4, pp. 177-180, 2008.
102. E. Garonna, K. M. Botham, G. M. Birdsey, A. M. Randi, R. R. Gonzalez-Perez, and C. P. D. Wheeler-Jones, "Vascular endothelial growth factor receptor-2 couples cyclo-oxygenase-2 with pro-angiogenic actions of leptin on human endothelial cells, " PLoS ONE, vol. 6, no. 4, Article ID e18823, 2011.
103. M. R. Schroeter, S. Stein, N.-M. Heida et al., "Leptin promotes the mobilization of vascular progenitor cells and neovascularization by NOX2-mediated activation of MMP9, " Cardiovascular Research, vol. 93, no. 1, pp. 170-180, 2012.
104. N.-M. Heida, M. Leifheit-Nestler, M. R. Schroeter et al., "Leptin enhances the potency of circulating angiogenic cells via src kinase and integrin v5: implications for angiogenesis in human obesity, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 2, pp. 200-206, 2010.
105. F. Amjadi, S. H. Javanmard, H. Zarkesh-Esfahani, M. Khazaei, and M. Narimani, "Leptin promotes melanoma tumor growth in mice related to increasing circulating endothelial progenitor cells numbers and plasma NO production, " Journal of Experimental and Clinical Cancer Research, vol. 30, no. 1, article 21, 2011.
106. R. Ferla, M. Bonomi, L. Otvos Jr., and E. Surmacz, "Glioblastoma-derived leptin induces tube formation and growth of endothelial cells: comparison with VEGF effects, " BMC Cancer, vol. 11, article 303, 2011.
107. S. Guo and R. R. Gonzalez-Perez, "Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer, " PLoS ONE, vol. 6, no. 6, Article ID e21467, 2011.
108. S. Loffreda, S. Q. Yang, H. Z. Lin et al., "Leptin regulates proinflammatory immune responses, " The FASEB Journal, vol. 12, no. 1, pp. 57-65, 1998.
109. V. Sánchez-Margalet, C. Martín-Romero, J. Santos-Alvarez, R. Goberna, S. Najib, and C. Gonzalez-Yanes, "Role of leptin as an immunomodulator of blood mononuclear cells:mechanisms of action, " Clinical and Experimental Immunology, vol. 133, no. 1, pp. 11-19, 2003.
110. G. Wolf, A. Hamann, D. C. Han et al., "Leptin stimulates proliferation and TGF-expression in renal glomerular endothelial cells: potential role in glomerulosclerosis, " Kidney International, vol. 56, no. 3, pp. 860-872, 1999.
111. H. Hsuchou, A. J. Kastin, H. Tu, N. Joan Abbott, P. O. Couraud, and W. Pan, "Role of astrocytic leptin receptor subtypes on leptin permeation across hCMEC/D3 human brain endothelial cells, " Journal of Neurochemistry, vol. 115, no. 5, pp. 1288-1298, 2010.
112. P. Singh, T. E. Peterson, K. R. Barber et al., "Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells, " Biochemical and Biophysical Research Communications, vol. 392, no. 1, pp. 47-52, 2010.
113. H. Wallaschofski, A. Kobsar, O. Sokolova et al., "Differences in platelet activation by prolactin and leptin, " Hormone and Metabolic Research, vol. 36, no. 7, pp. 453-457, 2004.
114. A. M. Thogersen, S. Söderberg, J.-H. Jansson et al., "Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction, " European Journal of Cardiovascular Prevention and Rehabilitation, vol. 11, no. 1, pp. 33-40, 2004.
115. N.-F. Chu, D. Spiegelman, G. S. Hotamisligil, N. Rifai, M. Stampfer, and E. B. Rimm, "Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men, " Atherosclerosis, vol. 157, no. 2, pp. 495-503, 2001.
116. S. Söderberg, B. Ahrén, J.-H. Jansson et al., "Leptin is associated with increased risk ofmyocardial infarction, " Journal of Internal Medicine, vol. 246, no. 4, pp. 409-418, 1999.
117. J. Mayszko, S. Woczynski, J. Mayszko, and M. Mysliwiec, "Leptin correlates with some hemostatic parameters in CAPD patients, " Nephron, vol. 92, no. 3, pp. 721-724, 2002.
118. T. Chiba, S. Shinozaki, T. Nakazawa et al., "Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice, " Atherosclerosis, vol. 196, no. 1, pp. 68-75, 2008.
119. K. Kotani, N. Sakane, K. Saiga, and Y. Kurozawa, "Leptin: adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: relationship of the index to carotid intimamedia thickness, " Diabetologia, vol. 48, no. 12, pp. 2684-2686, 2005.
120. G. D. Norata, S. Raselli, L. Grigore et al., "Leptin: adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery, " Stroke, vol. 38, no. 10, pp. 2844-2846, 2007.
121. N. Satoh, M. Naruse, T. Usui et al., "Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients, " Diabetes Care, vol. 27, no. 10, pp. 2488-2490, 2004.
122. S. Kumagai, H. Kishimoto, M. Suwa, B. Zou, and H. Sasaki, "The leptin to adiponectin ratio is a good biomarker for the prevalence of metabolic syndrome, dependent on visceral fat accumulation and endurance fitness in obese patients with diabetes mellitus, " Metabolic Syndrome and Related Disorders, vol. 3, no. 2, pp. 85-94, 2005.
123. E. Galluccio, P. Piatti, L. Citterio et al., "Hyperinsulinemia and impaired leptin-adiponectin ratio associate with endothelial nitric oxide synthase polymorphisms in subjects with in-stent restenosis, " American Journal of Physiology-Endocrinology and Metabolism, vol. 294, no. 5, pp. E978-E986, 2008.
124. G. Labruna, F. Pasanisi, C. Nardelli et al., "High leptin/adiponectin ratio and serum triglycerides are associated with an 'atrisk phenotype in young severely obese patients, " Obesity, vol. 19, no. 7, pp. 1492-1496, 2011.
125. J. E. Yun, S. Won, Y. Mok, W. Cui, H. Kimm, and S. H. Jee, "Association of the leptin to high-molecular-weight adiponectin ratio with metabolic syndrome, " Endocrine Journal, vol. 58, no. 9, pp. 807-815, 2011.
126. J. I. Hall, N. Vora, R. Langworthy et al., "Leptin/adiponectin ratio in patients with coronary heart disease: comparing subjects with and without metabolic syndrome, " Annals of Clinical Biochemistry, vol. 48, no. 4, pp. 327-331, 2011.